Clinical Trial Update: Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating infusion of mesenchymal stem cells as treatment for steroid-resistant acute graft-versus-host di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Low Donor T-cell Chimerism
• Poor Graft Function

Drugs mentioned

• Mesenchymal Stem Cell Infusion

Snippet

Sponsor: University of Liege | Conditions: Graft-versus-host Disease, Poor Graft Function | Phase 2 | Status: RECRUITING